Back to results
CompletedPhase 2

Tesmilifene in Combination With Docetaxel in the Treatment of Metastatic Breast Cancer

NCT00364195

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Clinical Hospital Center Bezanijska Kosa

Belgrade, Serbia

+2 additional locations

View on ClinicalTrials.gov
Tesmilifene in Combination With Docetaxel in the Treatment of Metastatic Breast Cancer — TrialFind